Irinotecan and 5-Fluorouracil in colorectal cancer: time for a pause?
-
Published:1998-02
Issue:3
Volume:34
Page:286-289
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Subject
Cancer Research,Oncology
Reference36 articles.
1. Devita Jr VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. Philadelphia, JB Lippincott, 1996.
2. Advanced Colorectal Cancer Meta Analysis Project: modulation of fluorouracil by leukovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Meta Analysis Project. J Clin Oncol 1992, 10, 896–903.
3. Rougier P, Culine S, Bugat R, et al. A phase II study of CPT-11 (irinotecan) in the treatment of advanced colorectal cancer in chemotherapy naive patients and patients pre-treated with 5-FU based chemotherapy. J Clin Oncol 1997, 15, 251-260.
4. Conti JA, Kemeny NE, Salts LB, et al. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol 1996, 14, 709–715.
5. Armand JP, Ducreux M, Mahjoubi M, et al. CPT-11 (irinotecan) in the treatment of colorectal cancer. Eur J Cancer 1995, 31A, 1283–1287.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献